15-86224904-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_001386094.1(AGBL1):c.489-10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0142 in 1,613,060 control chromosomes in the GnomAD database, including 215 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.010 ( 12 hom., cov: 31)
Exomes 𝑓: 0.015 ( 203 hom. )
Consequence
AGBL1
NM_001386094.1 intron
NM_001386094.1 intron
Scores
2
Splicing: ADA: 0.0003197
2
Clinical Significance
Conservation
PhyloP100: 0.436
Genes affected
AGBL1 (HGNC:26504): (AGBL carboxypeptidase 1) Polyglutamylation is a reversible posttranslational modification catalyzed by polyglutamylases that results in the addition of glutamate side chains on the modified protein. This gene encodes a glutamate decarboxylase that catalyzes the deglutamylation of polyglutamylated proteins. Mutations in this gene result in dominant late-onset Fuchs corneal dystrophy. [provided by RefSeq, Nov 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 15-86224904-C-T is Benign according to our data. Variant chr15-86224904-C-T is described in ClinVar as [Benign]. Clinvar id is 3038387.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0104 (1588/152184) while in subpopulation SAS AF= 0.027 (130/4814). AF 95% confidence interval is 0.0232. There are 12 homozygotes in gnomad4. There are 780 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1588 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGBL1 | NM_001386094.1 | c.489-10C>T | intron_variant | ENST00000614907.3 | NP_001373023.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGBL1 | ENST00000614907.3 | c.489-10C>T | intron_variant | 5 | NM_001386094.1 | ENSP00000490608.2 | ||||
AGBL1 | ENST00000441037.7 | c.489-10C>T | intron_variant | 5 | ENSP00000413001.3 |
Frequencies
GnomAD3 genomes AF: 0.0104 AC: 1588AN: 152066Hom.: 12 Cov.: 31
GnomAD3 genomes
AF:
AC:
1588
AN:
152066
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0135 AC: 3367AN: 248926Hom.: 28 AF XY: 0.0149 AC XY: 2013AN XY: 135056
GnomAD3 exomes
AF:
AC:
3367
AN:
248926
Hom.:
AF XY:
AC XY:
2013
AN XY:
135056
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0146 AC: 21381AN: 1460876Hom.: 203 Cov.: 31 AF XY: 0.0150 AC XY: 10932AN XY: 726724
GnomAD4 exome
AF:
AC:
21381
AN:
1460876
Hom.:
Cov.:
31
AF XY:
AC XY:
10932
AN XY:
726724
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0104 AC: 1588AN: 152184Hom.: 12 Cov.: 31 AF XY: 0.0105 AC XY: 780AN XY: 74396
GnomAD4 genome
AF:
AC:
1588
AN:
152184
Hom.:
Cov.:
31
AF XY:
AC XY:
780
AN XY:
74396
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
21
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
AGBL1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 15, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at